Biodesix Ownership
| BDSX Stock | USD 1.43 0.01 0.69% |
Shares in Circulation | First Issued 2017-12-31 | Previous Quarter 127.2 M | Current Value 146.3 M | Avarage Shares Outstanding 50.4 M | Quarterly Volatility 33.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Biodesix |
Biodesix Stock Ownership Analysis
About 49.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.37. Biodesix had not issued any dividends in recent years. Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado. Biodesix operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 218 people. For more info on Biodesix please contact Scott Hutton at 303 417 0500 or go to https://www.biodesix.com.Besides selling stocks to institutional investors, Biodesix also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Biodesix's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Biodesix's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Biodesix Quarterly Liabilities And Stockholders Equity |
|
About 49.0% of Biodesix are currently held by insiders. Unlike Biodesix's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Biodesix's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Biodesix's insider trades
Biodesix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Biodesix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biodesix backward and forwards among themselves. Biodesix's institutional investor refers to the entity that pools money to purchase Biodesix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Lmr Partners Llp | 2024-06-30 | 1.6 M | Essex Investment Management Company, Llc | 2024-09-30 | 971.2 K | Wells Fargo & Co | 2024-06-30 | 931.2 K | Geode Capital Management, Llc | 2024-09-30 | 804.6 K | Perkins Capital Management Inc | 2024-09-30 | 724.8 K | Amh Equity Ltd | 2024-09-30 | 696.1 K | Blackrock Inc | 2024-06-30 | 415.9 K | Legato Capital Management Llc | 2024-09-30 | 334.3 K | State Street Corp | 2024-06-30 | 288.6 K | Telemark Asset Management, Llc | 2024-09-30 | 8.3 M | Soleus Capital Management, L.p. | 2024-06-30 | 6.1 M |
Biodesix Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biodesix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biodesix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biodesix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Biodesix Outstanding Bonds
Biodesix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biodesix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biodesix bonds can be classified according to their maturity, which is the date when Biodesix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.